Scientists say they’ve come up with a way for the body to produce its own store of glucagon-like peptide-1 (GLP-1). The idea is to coax existing cells into producing the hormone, reaping the benefits of GLP-1 drugs without ongoing treatment. Promisingly, obesity rates have also started to decline since 2022, with experts suspicious that GLP-1 drugs have contributed to the trend. Normal-weight mice also didn’t gain any weight and maintained healthy blood sugar levels after being treated and given a high-fat diet. More on GLP-1s: Trump Strikes Deal to Offer Americans GLP-1 Drugs for Much Cheaper